Key stats
About PENGHUA FUND MGT
Home page
Inception date
Feb 22, 2023
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Penghua Fund Management Co., Ltd.
ISIN
CNE100005WG5
Tightly track the target index, and pursue the minimization of tracking deviation and tracking err. The Fund strives to control the daily average tracking deviation within 0.2% , and the annual tracking err within 2% .
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.62%
Health Technology94.39%
Transportation3.09%
Health Services0.82%
Commercial Services0.32%
Bonds, Cash & Other1.38%
Cash1.38%
Stock breakdown by region
Asia98.80%
Europe1.20%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159657 invests in stocks. The fund's major sectors are Health Technology, with 94.39% stocks, and Transportation, with 3.09% of the basket. The assets are mostly located in the Asia region.
159657 top holdings are Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A and Changchun High-Tech Industry (Group) Co., Ltd. Class A, occupying 10.40% and 9.85% of the portfolio correspondingly.
No, 159657 doesn't pay dividends to its holders.
159657 shares are issued by Penghua Fund Management Co., Ltd. under the brand Penghua. The ETF was launched on Feb 22, 2023, and its management style is Passive.
159657 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159657 follows the CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159657 invests in stocks.